Use of Oligomeric Formulas in Malabsorption: A Delphi Study and Consensus
Nutrients · 2025
DOI: 10.3390/nu17091426 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift Nutrients, 2025. Verfasst von Carmelo Diéguez Castillo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Specialist in Gastroenterology, Hospital Universitario Torrecárdenas, 04009 Almería, Spain. Hauptthemen laut MEDLINE: Malabsorption Syndromes, Enteral Nutrition, Food, Formulated. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott laboratories.
Abstract (Originalsprache)
Background
Malabsorption syndrome is characterized by chronic diarrhea, abdominal distension, and malnutrition, thereby complicating its diagnosis and treatment. Oligomeric enteral formulas, designed to facilitate absorption in patients with compromised bowel function, have shown clinical efficacy, though their implementation lacks standardization due to the lack of uniform protocols.
Objective
To establish a multidisciplinary consensus on the use of oligomeric formulas in patients with malabsorption using a Delphi methodology. Material and Method: A Delphi study was conducted with 156 specialists in endocrinology, gastroenterology, oncology, and internal medicine. Two rounds of structured surveys assessed clinical practices, associated symptoms, and the use of oligomeric enteral formulas. Data were analyzed using descriptive statistics and non-parametric tests, defining consensus with a median of ≥7 and an interquartile range of ≤3. Likewise, a Median (MED) score of ≤3 was considered as a consensus to reject the statement, while an Interquartile range (IQR) of ≥4 or a MED of 4–6 was considered as no agreement. These statements were reviewed and included in the second round.
Results
Screening for malnutrition is widely supported (79%), but only 38% of participants reported having specific management protocols. Symptoms such as abdominal distension, abdominal pain, and diarrhea were identified as key predictors of intolerance to polymeric formulas, establishing oligomeric enteral formulas as first choice in these cases. In addition, the effectiveness of an approach that progresses from oligomeric to polymeric enteral formulas once symptoms have stabilized was highlighted. The need for standardized protocols was recognized as a priority to guide nutritional assessment and treatment in patients with malabsorption.
Conclusions
This consensus reinforces the importance of implementing specific clinical protocols for the nutritional management of malabsorption, including the initial use of oligomeric enteral formulas in patients with severe symptoms and their controlled transition to polymeric enteral formulas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Specialist in Gastroenterology, Hospital Universitario Torrecárdenas, 04009 Almería, Spain.
- Internal Medicine Department, Infanta Elena Hospital, 21007 Huelva, Spain.
- Medical Department, Abbott Laboratories, 28050 Madrid, Spain.
- Center of Investigation Endocrinology and Nutrition, Valladolid University Clinical Hospital, Medicine School University, 47002 Valladolid, Spain.
ORCID-Profile: Daniel De Luis Román
Förderung
- Abbott laboratories
Zitieren
APA
Diéguez Castillo, C., Sidahi Serrano, M., Martín Aguilar, A., & De Luis Román, D. (2025). Use of Oligomeric Formulas in Malabsorption: A Delphi Study and Consensus. Nutrients. https://doi.org/10.3390/nu17091426
Vancouver
Diéguez Castillo C, Sidahi Serrano M, Martín Aguilar A, De Luis Román D. Use of Oligomeric Formulas in Malabsorption: A Delphi Study and Consensus. Nutrients. 2025. doi:10.3390/nu17091426
BibTeX
@article{DiguezCastillo2025,
author = {Diéguez Castillo, Carmelo and Sidahi Serrano, Maryam and Martín Aguilar, Andrea and De Luis Román, Daniel},
title = {Use of Oligomeric Formulas in Malabsorption: A Delphi Study and Consensus},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17091426}
}
EUVIMED